Breaking News Instant updates and real-time market news.

PCRX

Pacira

$36.10

0.2 (0.56%)

14:55
02/15/18
02/15
14:55
02/15/18
14:55

FDA panel votes against recommending nerve block indication for Exparel

The panel voted 6-4 against recommending approval for an indication for Exparel to produce local analgesia and as a nerve block to produce regional analgesia, according to various media reports of the panel meeting. Pacira Pharmaceuticals shares remain halted.

  • 15

    Feb

  • 21

    Feb

  • 06

    Apr

PCRX Pacira
$36.10

0.2 (0.56%)

02/13/18
PIPR
02/13/18
NO CHANGE
Target $49
PIPR
Overweight
Pacira briefing materials 'clearly a mixed bag,' says Piper Jaffray
Briefing materials for the upcoming meeting of the FDA's Anesthetic and Analgesic Drug Products Advisory Committee to discuss Pacira Pharmaceuticals' filing for Exparel administration via upper and lower extremity nerve block were "clearly a mixed bag," Piper Jaffray analyst David Amsellem tells investors in a research note. He believes this is not a surprise since the results of the studies supporting the filing were a "mixed bag." The analyst's read of the documents suggests that a label expansion in femoral nerve block is "likely off the table." That said, the documents did not focus significantly on the successful upper extremity study, and the voting questions clearly leave open the possibility of a narrow label expansion, Amsellem contends. He reiterates an Overweight rating on Pacira with a $49 price target.
02/12/18
BMOC
02/12/18
NO CHANGE
BMOC
Market Perform
BMO says Pacira briefing docs reveal 'several uncertainties' for Exparel
BMO Capital analyst Gary Nachman said his quick review of the FDA's analysis and draft questions for the upcoming advisory committee meeting reveal "several uncertainties" about Exparel in terms of consistency across studies and how the drug compares with IR bupivacaine. On efficacy, the FDA "appears to be cautious" about providing a broad label for nerve block, said Nachman, who keeps a Market Perform rating on Pacira shares.
02/07/18
PIPR
02/07/18
NO CHANGE
Target $49
PIPR
Overweight
Piper 'cautiously optimistic' into Pacira FDA advisory panel
Piper Jaffray analyst David Amsellem remains "cautiously optimistic" on a favorable outcome into the FDA's Anesthetic and Analgesic Drug Products Advisory Committee meeting on February 14 and 15 to discuss Pacira Pharmaceuticals' supplemental new drug application filing for Exparel administration via upper and lower extremity nerve block. The analyst continues to believe that Exparel, even without a label expansion, is well positioned for "significant and sustainable" growth. He reiterates an Overweight rating on Pacira with a $49 price target.
01/19/18
GHSC
01/19/18
INITIATION
Target $51
GHSC
Buy
Pacira initiated with a Buy at Seaport Global
Seaport Global analyst Corey David initiated Pacira with a Buy and $51 price target. The analyst believes Exparel growth rates have bottomed and will begin to reaccelerate in 2018.

TODAY'S FREE FLY STORIES

BIG

Big Lots

06:07
12/10/18
12/10
06:07
12/10/18
06:07
Recommendations
Big Lots analyst commentary  »

Big Lots price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUBC

Subsea 7 SA

$0.00

(0.00%)

06:07
12/10/18
12/10
06:07
12/10/18
06:07
Upgrade
Subsea 7 SA rating change  »

Subsea 7 SA upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTI

TechnipFMC

06:07
12/10/18
12/10
06:07
12/10/18
06:07
Upgrade
TechnipFMC rating change  »

TechnipFMC upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

WAGE

WageWorks

06:06
12/10/18
12/10
06:06
12/10/18
06:06
Upgrade
WageWorks rating change  »

WageWorks upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

COF

Capital One

$82.66

-1.93 (-2.28%)

06:06
12/10/18
12/10
06:06
12/10/18
06:06
Upgrade
Capital One rating change  »

Capital One upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

RDWR

Radware

$22.34

-0.35 (-1.54%)

06:06
12/10/18
12/10
06:06
12/10/18
06:06
Hot Stocks
Radware announces major deal with global cloud provider »

Radware announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWKS

Skyworks

$67.56

-3.04 (-4.31%)

06:06
12/10/18
12/10
06:06
12/10/18
06:06
Downgrade
Skyworks rating change  »

Skyworks downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QRVO

Qorvo

$61.16

-1.58 (-2.52%)

06:05
12/10/18
12/10
06:05
12/10/18
06:05
Downgrade
Qorvo rating change  »

Qorvo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

IMOS

ChipMOS

$17.20

-0.69 (-3.86%)

06:05
12/10/18
12/10
06:05
12/10/18
06:05
Earnings
Breaking Earnings news story on ChipMOS »

ChipMOS reports November…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GV

Goldfield Corp

$2.32

-0.035 (-1.49%)

06:05
12/10/18
12/10
06:05
12/10/18
06:05
Hot Stocks
Goldfield Corp announces resumption of stock repurchase program »

The Goldfield Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCWX

Secureworks

$15.65

-1.52 (-8.85%)

06:05
12/10/18
12/10
06:05
12/10/18
06:05
Downgrade
Secureworks rating change  »

Secureworks downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSANY

Nissan

$0.00

(0.00%)

06:05
12/10/18
12/10
06:05
12/10/18
06:05
Periodicals
Ghosn, Nissan formally indicted in Japan, Bloomberg reports »

Carlos Ghosn and Nissan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

SNN

Smith & Nephew

$37.97

0.76 (2.04%)

06:05
12/10/18
12/10
06:05
12/10/18
06:05
Upgrade
Smith & Nephew rating change  »

Smith & Nephew…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADS

Alliance Data

$180.43

-6.725 (-3.59%)

06:04
12/10/18
12/10
06:04
12/10/18
06:04
Upgrade
Alliance Data rating change  »

Alliance Data upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

SNCR

Synchronoss

06:04
12/10/18
12/10
06:04
12/10/18
06:04
Upgrade
Synchronoss rating change  »

Synchronoss upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABB

ABB

$18.86

-0.375 (-1.95%)

06:04
12/10/18
12/10
06:04
12/10/18
06:04
Upgrade
ABB rating change  »

ABB upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

EQT

EQT Corporation

$18.42

0.41 (2.28%)

06:04
12/10/18
12/10
06:04
12/10/18
06:04
Hot Stocks
Rice leadership team sends letter to EQT Corporation detailing path forward »

Toby Z. Rice and Derek A.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

X

U.S. Steel

$21.30

-0.7 (-3.18%)

06:03
12/10/18
12/10
06:03
12/10/18
06:03
Upgrade
U.S. Steel rating change  »

U.S. Steel upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TVTY

Tivity Health

$40.60

-0.27 (-0.66%)

, NTRI

Nutrisystem

$34.19

-1.07 (-3.03%)

06:02
12/10/18
12/10
06:02
12/10/18
06:02
Hot Stocks
Breaking Hot Stocks news story on Tivity Health, Nutrisystem »

Tivity Health to acquire…

TVTY

Tivity Health

$40.60

-0.27 (-0.66%)

NTRI

Nutrisystem

$34.19

-1.07 (-3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$263.68

-5.98 (-2.22%)

06:01
12/10/18
12/10
06:01
12/10/18
06:01
Periodicals
President Xi tells lieutenants to 'follow through' on Trump agreement, WSJ says »

Chinese officials have…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$263.68

-5.98 (-2.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NGVT

Ingevity

$85.15

-5.32 (-5.88%)

05:58
12/10/18
12/10
05:58
12/10/18
05:58
Hot Stocks
Ingevity to acquire Capa caprolactone division of Perstorp Holding AB »

Ingevity announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSM

TSMC

$36.52

-0.33 (-0.90%)

05:58
12/10/18
12/10
05:58
12/10/18
05:58
Hot Stocks
TSMC reports November revenue NT$98.39B, up 5.6% y/y »

TSMC announced its net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COR

CoreSite Realty

$97.28

-2 (-2.01%)

, DLR

Digital Realty

$115.80

-1.135 (-0.97%)

05:53
12/10/18
12/10
05:53
12/10/18
05:53
Downgrade
CoreSite Realty, Digital Realty, Equinix rating change  »

CoreSite Realty…

COR

CoreSite Realty

$97.28

-2 (-2.01%)

DLR

Digital Realty

$115.80

-1.135 (-0.97%)

EQIX

Equinix

$386.76

-6.1 (-1.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

APDN

Applied DNA Sciences

$1.08

0.02 (1.89%)

05:52
12/10/18
12/10
05:52
12/10/18
05:52
Hot Stocks
Applied DNA Sciences signs joint development agreement with Everledger »

Applied DNA Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

EQIX

Equinix

$386.76

-6.1 (-1.55%)

05:51
12/10/18
12/10
05:51
12/10/18
05:51
Upgrade
Equinix rating change  »

Equinix upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.